Advertisement
Product › Details
Lampit®
Next higher product group | nifurtimox | |
Status | 2001-06-13 sales existent | |
Organisation | Bayer AG | |
Group | Bayer (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for anti-infective drug_o
- [1] Peptilogics. (12/21/20). "Press Release: Peptilogics Closes $35.4 Million Series B Financing to Further Advance Proprietary Computational Peptide Drug Design and Discovery Platform". Pittsburgh, PA....
- [2] NovaBiotics Ltd.. (10/16/20). "Press Release: NovaBiotics Secures £1 Million in Funding from Innovate UK to Support Clinical Development of Nylexa for COVID-19". Aberdeen....
- [3] Peptilogics. (2/25/20). "Press Release: Peptilogics Announces CARB-X Funding to Accelerate Development of First-in-Class Antibiotics to Address the Rising Global Threat of Drug-Resistant Bacteria"....
- [4] Novartis AG. (2/13/19). "Press Release: Novartis Receives FDA Approval for Egaten for the Treatment of Fascioliasis, a Neglected Tropical Disease". Basel....
- [5] Sanofi S.A.. (1/30/19). "Press Release: Fexinidazole, the First All-oral Treatment for Sleeping Sickness, Approved in Democratic Republic of Congo". Paris & Geneva....
- [6] Sanofi S.A.. (1/31/18). "Press Release: Sanofi, DNDi Seek European Medicines Agency Review for Sleeping Sickness Treatment". Paris & Geneva....
- [7] AiCuris Anti-infective Cures GmbH. (8/1/17). "Press Relase: AiCuris Granted Fast Track Designation by U.S. FDA for Oral Pritelivir for Treatment of HSV Infections in Immunocompromised Adults". Wuppertal....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top